Need to keep on prime of the science and politics driving biotech at the moment? Join to get our biotech e-newsletter in your inbox.
Hiya. Right now, we discover a gene remedy strategy that’s drawing pleasure but in addition skepticism, and see that Jennifer Doudna is transferring into AI-designed gene editors that push past evolution.
Plus, our trusty podcasters unpack the buzzy prediction market Kalshi’s transfer into biotech.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans
